New FOA: Integrating Biospecimen Science Approaches
into Clinical Assay Development (U01)
This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development due to biopsy biospecimen preanalytical variability. New, additional submission dates:
February 13, 2017; October 11, 2017; June 22, 2018.
The 2016 version of the
NCI Best Practices for Biospecimen Resources
This foundational document for biobanking has been updated and revised to provide more current and detailed recommendations related to biospecimen and data quality.
New Version of Biospecimen Research Database Available!
The BRD is a free and publicly accessible literature database that contains peer-reviewed primary and review articles in the field of human Biospecimen Science. New features include a dynamic homepage, enhanced search options (such as keyword search), and user commenting.
Welcome to the Biorepositories and Biospecimen Research Branch!
The Biorepositories and Biospecimen Research Branch (BBRB) of the Cancer Diagnosis Program (CDP) provides leadership, tools, resources, and policies in biobanking for the global biomedical research community, to enable translational research and precision medicine for patients. BBRB develops biorepository standards and facilitates Biospecimen Science studies that form the basis of evidence-based practices to guide clinical cancer research and other biomedical studies which utilize biospecimens.
News and Announcements
There are currently no scheduled events